These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1153264)

  • 1. [Price control on drugs in Norway].
    Halse M
    Nord Med; 1975 Mar; 90(3):92-3. PubMed ID: 1153264
    [No Abstract]   [Full Text] [Related]  

  • 2. [Price control on drugs].
    Nord Med; 1975 Mar; 90(3):91-2. PubMed ID: 1153263
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug prices and public control].
    Halse M
    Nord Med; 1975 Oct; 90(10):244-6. PubMed ID: 1187335
    [No Abstract]   [Full Text] [Related]  

  • 4. [Consequences of changing from fixed amount payments to percentage payment of drugs].
    Berg SH; Aasmundstveit O; Saanum DT
    Tidsskr Nor Laegeforen; 1990 Oct; 110(26):3391-4. PubMed ID: 2256066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of price control on drug expenses in Finland].
    Salonen R; Idänpään-Heikkilä J
    Nord Med; 1975 Mar; 90(3):90-1. PubMed ID: 1153262
    [No Abstract]   [Full Text] [Related]  

  • 6. Price controls and global pharmaceutical progress.
    Scherer FM
    Health Aff (Millwood); 2009; 28(1):w161-4. PubMed ID: 19088103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
    Führlinger S
    Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent trends in drug prescribing rates and costs in New Zealand.
    Malcolm LA; Mehl A
    N Z Med J; 1988 May; 101(845):233-6. PubMed ID: 3368132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to pay less for prescription drugs.
    Consum Rep; 1975 Jan; 40(1):48-53. PubMed ID: 1244036
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparisons of the costs of psychotropic medications: an update.
    Jurman RJ; Davis JM
    Psychiatr Med; 1991; 9(2):349-59. PubMed ID: 1677482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily cost of ophthalmic solutions used to treat allergic conjunctivitis in Japan.
    Ikeda H; Tsukamoto H; Sato E; Mishima HK; Kihira K
    Ophthalmic Epidemiol; 2004 Feb; 11(1):35-42. PubMed ID: 14977495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marketing Medicaid drugs: an analysis of cost factors.
    Simmons SA; Payne BC; Smith MC
    J Health Care Mark; 1986 Sep; 6(3):29-36. PubMed ID: 10301037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care cost control by third party payors: fee schedules and the Sherman Act.
    Kallstrom DW
    Duke Law J; 1978 May; (2):645-97. PubMed ID: 10239068
    [No Abstract]   [Full Text] [Related]  

  • 14. Price regulation and generic competition in the pharmaceutical market.
    Dalen DM; Strøm S; Haabeth T
    Eur J Health Econ; 2006 Sep; 7(3):208-14. PubMed ID: 16841230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medical problems associated with the national reference pricing system in Hungary].
    Kerpel-Fronius S
    Orv Hetil; 2004 Apr; 145(17):913-8. PubMed ID: 15170969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Hospital charges for pharmaceutical services.
    Zellmer WA
    Am J Hosp Pharm; 1974 Nov; 31(11):1043. PubMed ID: 4432851
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug consumption and drug compensation].
    Asbrink A
    Nord Med; 1970 Sep; 84(39):1249. PubMed ID: 5469311
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rational use of antibiotics. Socioeconomic problems].
    Cah Med; 1971 Dec; 12(17):1538-44. PubMed ID: 5149499
    [No Abstract]   [Full Text] [Related]  

  • 19. Excess profits in the drug industry and their effect on consumer expenditures.
    Doherty N
    Inquiry; 1973 Sep; 10(3):19-30. PubMed ID: 4269726
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmaceutical reference pricing in Germany: definition of therapeutic groups, price setting through regression procedure and effects].
    Stargardt T; Schreyögg J; Busse R
    Gesundheitswesen; 2005 Jul; 67(7):468-77. PubMed ID: 16103970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.